PPT-An Update on Reversal Agents for NOACs: Where Are

We Now Moderator Christian T Ruff MD MPH Assistant Professor of Medicine TIMI Study Group Brigham and Womens Hospital Harvard Medical School Boston Massachusetts Arash Afshinnik MD. New KODAK TRIX Reversal Film 7266 offers finer grain and increased sharpness and includes EASTMAN KEYKODE Numbers for easy crossreference of shots in minutes not hours Reduced static support allows for a cleaner image throughout the filmmaking proce G. . Turpie. Professor Emeritus of Medicine. McMaster University. Hamilton ON. Canada. Future Challenges. Disclosures for Dr A.G.G. Turpie. Research Support. None. Employee. None. Consultant and/or Honoraria. Violation of procedure invariance. Wrap up of the previous lecture. Two hypotheses competing for the behavioral foundation of economic theory: . DPH. , according to which preferences are stable and . By end of year one competing, . with goal to win a buckle. . May. 2014 Luke. After 5 Days. Why I did not Win. Because Life Is Not . Fair?. I Did Not Win Because. My ability was . below. what was required to . . What Do the Data Suggest? . Testing for NOAC Levels. re-verse . AD . Reversal Agents. Reversal Agents in Clinical Practice. BRIDGE Study. Managing Bleeding Complications. Reversal Agents. Abbreviations. Enter T-Code . ZFP08. Document Reversal . Enter Document No. and Reversal Reason. Document Reversal . Display Document to be reversed. Document Reversal . Document reversed. Document Reversal . Exceptions to Reversals. Program Goals. ERAS Definition. Achieving ERAS. Goals of ERAS. Anesthesia Roles in ERAS. NMB and Reversal as an Element . of ERAS. Purpose of NMB and Types of NMBAs. Nondepolarizing NMBA Reversal. PRNB. , . BCPS, BCCCP. Associate Professor | Department of Pharmacy Practice. Anticoag. : Update on Pipeline Agents for TSOAC . Reversal. Conflict of Interest. I have no actual or potential conflicts of interest in relation to this program to disclose.. Introduction/Overview . VKA-Associated Bleeding: . Results From the RADOA Registry . Reversal Agents for VKA-Associated Anticoagulation. Management of Urgent Anticoagulation Reversal: . 4F-PCC vs FFP. The Best of Both Worlds in CAD/PAD: The Emerging Role of Anticoagulants Program Goals Anticoagulants in CAD PAD and AP Therapies Antithrombotic Strategies for PAD Antithrombotic Strategies for PAD (cont) Meta-Analysis of NOACs vs Warfarin. RCT vs Real-World Data. Screening for Atrial Fibrillation to Prevent Strokes. Silent AF. Screening for AF. Devices for Long-Term AF Screening. Regular Pulse Check for Detecting AF. March 26 - * CUDA Learning Environment Steven Dalton, Iuri Frosio, Jared Hoberock, Jason Clemons CULE *: GPU ACCELERATED RL Reinforcement Learning time 2 REINFORCEMENT LEARNING A successful approach A partnership between Nebraska Medicine, UNMC , community-based organizations and primary care sites. This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling 751,695.00 with 0% financed with non-governmental sources. . Content. : Eljim Tesoro, PharmD, BCCCP, FNCS, FCCM;. Mehrnaz Pajoumand, PharmD . Slides. : Eljim Tesoro, PharmD, BCCCP, FNCS, FCCM .  .  .  .  . Editors’ Note: Global Considerations. The intent of the editors, authors, and reviewers of this ENLS topic was not to address all the variations in international practice for the different diseases. We have discussed major practice variances (e.g., the availability of diagnostic testing, or the type of medications used) and encourage learners to use the ENLS algorithms as a framework on which any relevant local practice guidelines can be incorporated..